Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003

NEXT STORY
Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac’s Type A Meeting with FDA on Treosulfan
PREV STORY
Monte Rosa Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe

author_avatar
NASDAQ Market News

Key Opinion Leader Management – Global Industry Analysis and Opportunity Assessment by 2026 | Future Market Insights

Valley Cottage, NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Key opinion leaders (KOLs) are ...

author_avatar
NASDAQ Market News

New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis

author_avatar
NASDAQ Market News